1,3-dimethyl-butanediyldiamine | 105394-93-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1,3-dimethyl-butanediyldiamine
• 英文别名: 1,3-Dimethyl-butandiyldiamin；(racemic+meso) 2-Methyl-pentane-1,4-diamine；2-methylpentane-1,4-diamine
• CAS: 105394-93-2
• 化学式: C₆H₁₆N₂
• mdl: MFCD19205091
• 分子量: 116.206
• InChiKey: ACEKLXGWCBIDGA-UHFFFAOYSA-N

物化性质

• 沸点：
  169.5±8.0 °C(Predicted)
• 密度：
  0.856±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  8
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  52
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  4-hydroxyimino-2-methyl-valeraldehyde-oxime 在 乙醇 、 sodium 作用下， 生成 1,3-dimethyl-butanediyldiamine
  参考文献：
  名称：

  Ciamician; Zanetti, Chemische Berichte, 1890, vol. 23, p. 1788

  摘要：

  DOI：

文献信息

• SUBSTITUTED TRIAZOLO-PYRIMIDINE COMPOUNDS FOR MODULATING CELL PROLIFERATION, DIFFERENTIATION AND SURVIVAL
  申请人：STATegics, Inc.

  公开号：US20140142122A1

  公开（公告）日：2014-05-22

  Disclosed herein are erythropoietin-mimetic compounds of Formula I, which modulate the survival, function, or differentiation of, for example, kidney cells, neurons, erythroid cells, or other erythropoietin-responsive cells. The present invention also relates to compounds and methods that preferentially modulate cells expressing the tissue-protective erythropoietin receptor. The compounds of the invention are useful in preventing and treating diseases, such as anemia, organ injury, and diseases of the central nervous system, and as an adjunct to cellular treatments, such as stem cell therapies.

  本公开涉及的是式I的类似促红细胞生成素化合物，其调节肾脏细胞、神经元、红细胞或其他促红细胞生成素反应细胞的存活、功能或分化。本发明还涉及优先调节表达组织保护性促红细胞生成素受体的细胞的化合物和方法。本发明的化合物在预防和治疗贫血、器官损伤、中枢神经系统疾病等疾病方面有用，并可作为干细胞治疗等细胞治疗的辅助手段。
• Thrombopoietin Mimetics
  申请人：Spencer Jeffrey R.

  公开号：US20080139621A1

  公开（公告）日：2008-06-12

  The invention relates to compounds and their use in the treatment of thrombocytopenia resulting from diseases or conditions such as immune thrombocytopenic purpura, cancer chemotherapy, surgery, bone marrow or stem cell transplantation, radiation injury or treatment, chronic viral infection, and pancytopenia. The invention further relates to pharmaceutical compositions containing the compounds and compositions of the invention as well as methods for treating such diseases or conditions in a mammal, including a human, by administering to such mammal an effective amount of a selected thrombopoietin receptor agonist.

  这项发明涉及化合物及其在治疗由疾病或状况引起的血小板减少症方面的用途，如免疫性血小板减少性紫癜、癌症化疗、手术、骨髓或干细胞移植、放射损伤或治疗、慢性病毒感染和全血细胞减少症。该发明还涉及含有这些化合物和该发明的组合物的药物组合物，以及通过向哺乳动物，包括人类，施用所选的血小板生成素受体激动剂的有效量来治疗这些疾病或状况的方法。
• BASE GENERATOR, PHOTOSENSITIVE RESIN COMPOSITION, PATTERN FORMING MATERIAL COMPRISING THE PHOTOSENSITIVE RESIN COMPOSITION, AND PATTERN FORMING METHOD AND ARTICLE USING THE PHOTOSENSITIVE RESIN COMPOSITION
  申请人：Katayama Mami

  公开号：US20110086311A1

  公开（公告）日：2011-04-14

  A photosensitive resin composition which is excellent in resolution, low in cost, and usable in a wide range of structures of polymer precursors each of which is reacted into a final product by a basic substance or by heating in the presence of a basic substance. The photosensitive resin composition includes a base generator which has a specific structure and generates a base by exposure to electromagnetic radiation and heating, and a polymer precursor which is reacted into a final product by the base generator and by a basic substance or by heating in the presence of a basic substance.

  一种光敏树脂组合物，具有分辨率优良、成本低廉和可用于一系列聚合物前体结构的特点，其中每种聚合物前体都可以通过碱性物质或在碱性物质的存在下加热反应成为最终产物。该光敏树脂组合物包括一种具有特定结构并通过电磁辐射和加热产生碱性物质的基发生剂，以及一种聚合物前体，该聚合物前体通过基发生剂和碱性物质或在碱性物质的存在下加热反应成为最终产物。
• TARGETED POLYLYSINE DENDRIMER THERAPEUTIC AGENT
  申请人：Krippner Guy Yeoman

  公开号：US20100292148A1

  公开（公告）日：2010-11-18

  The present invention relates generally to branched macromolecules bearing functional moieties. In particular, the invention relates to dendrimers, derived from lysine or lysine analogues, bearing a plurality of functional moieties. The invention further relates to the use of such macromolecules, particularly in therapeutic applications, and compositions comprising them.

  本发明通常涉及带有功能基团的分支大分子。特别是，本发明涉及从赖氨酸或赖氨酸类似物中派生出的树状分子，其带有多个功能基团。本发明还涉及这种大分子的使用，特别是在治疗应用中，以及包含它们的组合物。
• POLYLYSINE DENDRIMER CONTRAST AGENT
  申请人：Krippner Guy Yeoman

  公开号：US20100278750A1

  公开（公告）日：2010-11-04

  The present invention relates generally to branched macromolecules and their use as imaging or contrast agents. In particular, the invention relates to dendrimers, derived from lysine or lysine analogues, bearing a plurality of functional moieties and their application to imaging techniques in which a disease state may be imaged with a targeted contrast agent.

  本发明通常涉及分支大分子及其作为成像或对比剂的使用。具体而言，本发明涉及从赖氨酸或赖氨酸类似物派生的树状分子，带有多种功能基团，并将它们应用于成像技术中，其中可以使用定向对比剂成像疾病状态。